Compounds > thallium chloride
Page last updated: 2024-08-22

thallium chloride and Minimal Disease, Residual

thallium chloride has been researched along with Minimal Disease, Residual in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kasner, DL; Spieth, ME; Starkman, ME; Zdor-North, D1
Abdel-Dayem, HM; Botet, J; Divgi, CR; Healey, J; Kostakoglu, L; Larson, SM; Panicek, DM1
Ain, KB; Magoun, S; Pulmano, C; Shih, WJ; Stipp, V1

Other Studies

3 other study(ies) available for thallium chloride and Minimal Disease, Residual

ArticleYear
Thyroid carcinoma: iodine-131-negative whole-body scan reverses to positive after a combination of thyrogen stimulation and withdrawal.
    Clinical nuclear medicine, 2002, Volume: 27, Issue:11

    Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; False Negative Reactions; Female; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Longitudinal Studies; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Proteins; Solitary Pulmonary Nodule; Thallium; Thyroid Neoplasms; Thyrotropin; Thyroxine; Whole-Body Counting

2002
Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas.
    European journal of nuclear medicine, 1995, Volume: 22, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiography; Bone Neoplasms; Child; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Prospective Studies; Sarcoma; Sensitivity and Specificity; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

1995
Medullary thyroid carcinoma imaged by Tc-99m MIBI SPECT and Tl-201 chloride/Tc-99m pertechnetate subtraction SPECT.
    Clinical nuclear medicine, 1996, Volume: 21, Issue:3

    Topics: Carcinoma, Medullary; Humans; Male; Middle Aged; Neoplasm, Residual; Salivary Gland Neoplasms; Sodium Pertechnetate Tc 99m; Subtraction Technique; Technetium Tc 99m Sestamibi; Thallium; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon

1996